PURPOSE: Hand-sewn anastomosis as the gold standard of vascular anastomosis cannot fully meet the requirements of vascular anastomosis in speed and quality. Various vascular couplers have been developed to ameliorate this situation. Most of them are mainly used for venous anastomosis rather than arterial anastomosis. Although it is generally acknowledged that in almost all operations involving vascular reconstruction, it is the arteries that need to be anastomosed faster and more accurately and not the veins. A dedicated device is needed for creating arterial anastomosis in an easy, timesaving, less damaging but reliable procedure. Therefore, we plan to develop a novel arterial coupler device and test pre-clinical safety and effectiveness.
METHODS: In this cohort study, the rationality of this novel arterial coupler was preliminarily tested by finite element analysis before it was manufactured. Several factors restrict the use of vascular couplers in arterial anastomosis, such as arterial eversion, fixation, etc. The manufactured arterial couplers underwent in vitro and in vivo experiments. In vitro, isolated arteries of beagles were anastomosed with the assistance of an arterial coupler, and the anastomosed arteries were evaluated through anti-traction tests. In animal experiments, the bilateral femoral arteries of 5 beagles served as a control group. After dissection, the femoral artery on one side was randomly selected to be anastomosed with a quick arterial coupler (QAC) (QAC group), and the femoral artery on the other side was anastomosed by the same person using an end-to-end suture technique with a 6-0 Prolene suture (suture group). The bilateral femoral arteries of 5 beagles were used for coupler-assisted anastomosis and hand-sewn anastomosis in vivo, respectively. Success rate, blood loss, anastomotic time, clamp time, total operation time, and patency rate were recorded. The patency of anastomosed arteries was assessed using vascular Doppler ultrasound, electromagnetic flowmeter, and pathological examination (6 weeks after surgery).
RESULTS: As a novel arterial coupler, QAC was successfully designed and manufactured by using poly lactic-co-glycolic acid raw materials and 3-dimensions printing technology. Its rationality was preliminarily tested through finite element analysis and related mechanical analysis methods. The isolated arteries were successfully anastomosed with the assistance of QAC in vitro testing, which showed good anti-traction properties. In animal studies, QAC-assisted arterial anastomosis has superior profiles compared to hand-sewn anastomosis in anastomotic time (7.80 ± 1.41 vs. 16.38 ± 1.04 min), clamp time (8.80 ± 1.41 vs. 14.14 ± 1.57 min), and total operation time (46.64 ± 2.38 vs. 51.96 ± 3.65 min). The results of electromagnetic flowmeter, vascular Doppler ultrasound, and pathological examination showed that QAC-assisted anastomotic arteries were superior to hand-sewn arteries in terms of postoperative blood flow (16.86 ± 3.93 vs. 10.36 ± 0.92 mL/min) and vascular patency in 6 weeks after surgery.
CONCLUSION: QAC is a well-designed and easily maneuverable device specialized for end-to-end arterial anastomosis. Application of this device may decrease thermal ischemia time and improve the patency of anastomotic arteries, thus, improving outcomes.
Circulation. 2004 Sep 14;110(11 Suppl 1):II55-60
[PMID:
15364839]
Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H898-912
[PMID:
20035029]
Br J Oral Maxillofac Surg. 2021 Jan;59(1):16-20
[PMID:
32620301]
Comput Methods Programs Biomed. 2021 Sep;209:106328
[PMID:
34407452]
Perspect Vasc Surg Endovasc Ther. 2012 Dec;24(4):210-1
[PMID:
23969980]
Polymers (Basel). 2021 Apr 27;13(9):
[PMID:
33925498]
J Urol. 2006 Feb;175(2):636-40; discussion 640
[PMID:
16407013]
Eur Surg Res. 2022;63(2):55-63
[PMID:
34569485]
Interact Cardiovasc Thorac Surg. 2007 Feb;6(1):5-8
[PMID:
17669755]
Plast Reconstr Surg. 2024 Jan 1;153(1):168-171
[PMID:
37036316]
Cardiovasc Eng Technol. 2015 Sep;6(3):294-302
[PMID:
26577362]
Ultrasonics. 2012 Mar;52(3):402-11
[PMID:
22030473]
J Mech Behav Biomed Mater. 2021 Jul;119:104509
[PMID:
33865067]
J Thorac Cardiovasc Surg. 2004 Feb;127(2):498-503
[PMID:
14762360]
Biomed Microdevices. 2014 Feb;16(1):173-80
[PMID:
24081458]
J Vasc Surg. 2021 Jun;73(6):2098-2104
[PMID:
33249206]
Am J Physiol Cell Physiol. 2022 May 1;322(5):C875-C886
[PMID:
35196168]
J Mech Behav Biomed Mater. 2020 Dec;112:104022
[PMID:
32853863]
Sci Transl Med. 2017 Oct 4;9(410):
[PMID:
28978753]
Int J Pharm. 2021 Mar 15;597:120337
[PMID:
33549812]
Microsurgery. 2005;25(8):596-8
[PMID:
16284953]
Vet Surg. 2021 Jan;50(1):213-222
[PMID:
33103815]
Microsurgery. 2003;23(1):56-9
[PMID:
12616520]
Med Image Anal. 2021 Jul;71:102066
[PMID:
33951597]
J Plast Surg Hand Surg. 2015 Apr;49(2):72-6
[PMID:
25529101]
Br J Surg. 2003 Mar;90(3):261-71
[PMID:
12594661]
J Biomech. 2005 Aug;38(8):1574-81
[PMID:
15958213]
PLoS Biol. 2010 Jun 29;8(6):e1000412
[PMID:
20613859]
J Plast Reconstr Aesthet Surg. 2021 Jun;74(6):1286-1302
[PMID:
33551362]
Med Biol Eng Comput. 1992 Jul;30(4):413-8
[PMID:
1487942]
Biomaterials. 2000 Dec;21(23):2475-90
[PMID:
11055295]
Ann Plast Surg. 2006 Apr;56(4):365-8
[PMID:
16557063]
Nat Med. 2011 Aug 28;17(9):1147-52
[PMID:
21873986]
Materials (Basel). 2020 Apr 24;13(8):
[PMID:
32344744]
J Craniomaxillofac Surg. 2021 Mar;49(3):191-195
[PMID:
33454184]
Langenbecks Arch Surg. 2021 Sep;406(6):1943-1949
[PMID:
33877447]
J Thorac Cardiovasc Surg. 2004 Jan;127(1):185-92
[PMID:
14752430]
Pharm Res. 2017 Feb;34(2):301-309
[PMID:
27928646]
J Trauma Acute Care Surg. 2020 Dec;89(6):1183-1196
[PMID:
33230048]
Microsurgery. 2010 Sep;30(6):494-501
[PMID:
20238380]
Laryngoscope Investig Otolaryngol. 2020 Jul 18;5(4):683-688
[PMID:
32864439]
Laryngoscope. 2020 Jun;130(6):1428-1430
[PMID:
31517990]
J Hand Surg Eur Vol. 2019 Dec;44(10):1026-1030
[PMID:
31238778]
J Plast Reconstr Aesthet Surg. 2014 Jun;67(6):752-5
[PMID:
24631234]
Neurosurgery. 2020 Sep 15;87(4):697-703
[PMID:
31748798]
Front Surg. 2017 Aug 24;4:46
[PMID:
28884115]